Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |